Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases
NCT ID: NCT06587568
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
106 participants
INTERVENTIONAL
2024-10-02
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To assess whether the eligibility criteria were too restrictive by estimating the eligibility rate
2. To assess how many eligible CLD patients accepted the invitation to participate in the trial
3. To assess the participant retention rate through 6 months after treatment initiation
4. To assess the intervention acceptability in terms of participants' engagement with and rating of the chat messaging intervention.
5. To assess the safety of the intervention
6. To estimate the intervention effect on alcohol use outcomes and liver functions
7. To synthesise data to inform the sample size calculation in the future definitive trial
8. To explore the participants' perception and experiences in the chat-based intervention
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease
NCT03082703
Cardiovascular Health and Texting Messaging (CHAT) Study
NCT02888769
CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD
NCT07210710
Impact of Teach Back of Discharge Information in Term of Patient Recall of Information and Patient Engagement
NCT05280171
Text Messages for Liver Transplant Recipients
NCT04995770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mobile chat messaging
Mobile chat messaging + Screening-based alcohol intervention
Mobile chat messaging
A trained counsellor will interact with a participant individually and provide personalised alcohol reduction information and advice via a mobile instant messaging app in real time for 3 months from randomisation.
Screening, brief intervention and referral to treatment
Brief counselling (5 to 10 mins) to reduce drinking and a self-help booklet
Brief intervention
Screening-based alcohol intervention only
Screening, brief intervention and referral to treatment
Brief counselling (5 to 10 mins) to reduce drinking and a self-help booklet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile chat messaging
A trained counsellor will interact with a participant individually and provide personalised alcohol reduction information and advice via a mobile instant messaging app in real time for 3 months from randomisation.
Screening, brief intervention and referral to treatment
Brief counselling (5 to 10 mins) to reduce drinking and a self-help booklet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosed with chronic liver disease
3. Alcohol Use Disorders Identification Test score ≥8
4. Own a smartphone with a mobile instant messaging app installed
5. Able to read and communicate in Chinese
Exclusion Criteria
2. Participating in other alcohol reduction or abstinence programmes
3. Require emergency or in-patient treatment after consultation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health and Medical Research Fund
OTHER_GOV
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tzu Tsun Luk
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tzu Tsun Luk, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Mary Hospital
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21222731
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.